All Posts: clinical trials
-
Georgetown Study Explores THC/CBD Combination to Reduce Dementia-related Agitation at the End of Life
In a first-of-its-kind clinical trial, the Georgetown University Medical Center Memory Disorders Program will study the effects of an oral drug called T2:C100, which is comprised of two components found in marijuana — THC and CBD. The goal of the study is to investigate its potential to decrease agitation experienced by those with dementia at the end of life.
Category: News Release
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: GUMC Stories
-
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.
Category: News Release
-
Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials
Held by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center, the Ruesch Symposium brings together researchers, clinicians, patients, caregivers, policymakers and advocates for networking and discussion on the latest developments in GI cancer research and treatment.
Category: GUMC Stories
-
The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology
Category: News Release
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
Category: News Release
-
Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer
Category: GUMC Stories
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
Category: GUMC Stories
-
Clinical Research Staff Rise to the Challenges Posed by Pandemic
(July 31, 2020) — Running clinical research can be complicated under normal circumstances but it’s especially arduous during a pandemic. Despite the difficulties, the clinical research teams at Georgetown have worked tirelessly, remotely and on campus, to continue supporting researchers and study participants. “Our team as a whole really stepped up to do this, and […]
Category: GUMC Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
Category: GUMC Stories